Global Hematology Diagnostics Market Analysis, 2020
By Product Type (Hematology Instruments, Hematology Analyzer, Fully-automated hematology analyzer, Semi-automated hematology analyzer, Flow cytometers, Others), By End User (Hospitals and Clinics, Diagnostic Laboratories, Academic Institute, Commercial Service Providers, Others), By Consumables (Reagents, Stains, Controls and Calibrations, Others), By Region (North America, South America, Europe, Middle East & Africa and Asia-Pacific), By Country (United States, Canada, Mexico, Brazil, Argentina, Germany, Italy, United Kingdom, Spain, France, Saudi Arabia, UAE, South Africa, China, India, Japan, Australia, South Korea), By Company
The growing incidences of blood disorders coupled with rising geriatric population is surging the market growth of hematology diagnostics across the globe. North America is the largest market of hematology diagnostics with the prevalence of blood disorder cases and enhanced automated technology. According to the Centers for Disease Control and Prevention, around 70,000 to 100,000 Americans had sickle cell disease, a genetic blood disorder in 2019.
Historical Data: 2015-19
Base Year: 2019
Forecast Period: 2020-25
Middle East & Africa
According to the MarkNtel Advisors’ research report titled “Global Hematology Diagnostics Market Analysis, 2020”, the CAGR of the market is expected to be around 5.8% during 2020-25. The major factors contributing to the growth of hematology diagnostics are the technological advancements for new automated analyzers and testers, and rising blood-related disorders ranging from children to elders.
With the rising blood disorders such as thalassemia, the demand for hematology testing is surging. Hematology testing is majorly in demand by hospitals and diagnostic centers. With the growing prevalence of disorders such as leukemia and thalassemia, the demand for hematology testing is expected to show growth. The Leukemia and Lymphoma Society (LLS) predicted 1,74,250 new cases of leukemia, lymphoma or myeloma in the United States in 2018. Also, around 27% of the cases reported with blood-related disorders were found to be below the age group of 50 years, the majority below 20 years of age. These shifting dynamics has been translating into greater requirement of Hematology Diagnostics market.
Moreover, sales of hematology instruments with a high amount of screening and improved productivity along with flow cytometers are projected to fuel the market in forthcoming years. Hematology consumables including reagents, stains, controls, and calibrations acquired the largest market share owing to the product launches, acquisitions, and partnerships among the leading players. For instance, Danaher Corporation in 2018 received CE approval for its DxH 520 hematology analyzer in 2018.
These factors positively influenced the growth of hematology diagnostics. However, factors such as high cost, poor health insurance coverage for diagnostic procedures, and lack of professional knowledge is hindering the growth of hematology diagnostics during 2020-25. Besides, less awareness about blood disorders and limited availability of the products is currently hindering the growth of the hematology diagnostics during 2020-25.
According to the MarkNtel Advisors, the leading players operating in the Global Hematology Diagnostics market are Abbott Laboratories, Mindray Medical International, Siemens Healthneers, BioSystems, BioRad Laboratories, Horiba, Sysmex Corporation, Nihon Kohden Corporation, Danaher Corporation, F. Hoffman-La-Roche Ltd. among others.
Many manufacturers are launching new range of products and acquiring new businesses across borders for improving the technology and healthcare infrastructure, further driving the market growth of hematology diagnostics.
Key Questions Answered in the Market Research Report
What are the key market statistics (Market Overview, Market Size, Forecast, CAGR, Market Segmentation, Market Shares) of Global Hematology Diagnostics Market?
What are the key market or technology trends in Global Hematology Diagnostics Market?
What are the significant innovations, technology upgrades, opportunities, regulations, growth drivers and challenges in the Global Hematology Diagnostics Market?
Who are the key competitors or market players and how they perform in global competitive benchmarking matrix?
What are the key results derived from the market surveys conducted during the course of Global Hematology Diagnostics Market study?
Market Outlook, Segmentation and Statistics
Market Size & Forecast,
By Revenues (USD Billion)
By Volume (Units Sold)
Market Share & Forecast
By Product Type
Fully-automated hematology analyzer
Semi-automated hematology analyzer
By End User
Hospitals and Clinics
Commercial Service Providers
Controls and Calibrations
Middle East & Africa
Strategic Factorial Indexing
Competitor Placement in MarkNtel Quadrant
North America Hematology Diagnosticss Market Analysis, 2015-2025F (USD Billion)
South America Hematology Diagnosticss Market Analysis, 2015-2025F (USD Billion)
Europe Hematology Diagnosticss Market Analysis, 2015-2025F (USD Billion)
Middle East and Africa Hematology Diagnosticss Market Analysis, 2015-2025F (USD Billion)
Global Hematology Diagnosticss Market Policies, Regulations, Product Standards
Global Hematology Diagnosticss Market Hotspot & Opportunities
Global Hematology Diagnosticss Market Key Strategic Imperatives for Success & Growth
Global Competition Outlook
Frequently Asked Questions
Q. What is the historical year, base year and forecast year considered in the research report on Global Hematology Diagnostics Market?
A. The historical data has been provided since 2015, while the base year is 2019 and the data is forecasted up to 2025.
Q. What are the units or denomination for measuring market value and volume in the report?
A. The market size/industry size or the market value is measured in terms of USD Billion, while the market volume is measured in terms of units sold.
Q. What would be the CAGR of the Global Hematology Diagnostics Market during 2020 to 2025?
A. The market size of Global Hematology Diagnostics Market would register a CAGR of 5.8% during 2020-25.
Q. Does the report scope cover country wise market statistics also?
A. Yes, the scope of the report encompasses detailed country statistics such as market size, market segmentation based on various subcategories.
Q. Who are the key players or major competitors in Global Hematology Diagnostics Market?
A. Abbott Laboratories, Mindray Medical International, Siemens Healthneers, BioSystems, BioRad Laboratories, Horiba, Sysmex Corporation, Nihon Kohden Corporation, Danaher Corporation, F. Hoffman-La-Roche Ltd. etc. are few of the leading players with majority market share in Global Hematology Diagnostics Market.
1.1. Product Definition
1.2. Research Process
1.4. Market Segmentation
2. Executive Summary
3. Expert Verbatim- What our Experts Say?
4. Global Hematology Diagnostics Market Analysis, 2015-2025F
4.1. Market Size & Analysis
4.1.1. Market Revenue
4.2. Market Share & Analysis
4.2.1. By Product Type
184.108.40.206. Hematology Instruments
220.127.116.11. Hematology Analyzer
18.104.22.168. Fully-automated hematology analyzer
22.214.171.124. Semi-automated hematology analyzer
126.96.36.199. Flow cytometers
4.2.2. By End User
188.8.131.52. Hospitals and Clinics
184.108.40.206. Diagnostic Laboratories
220.127.116.11. Academic Institute
18.104.22.168. Commercial Service Providers
4.2.3. By Consumables
22.214.171.124. Controls and Calibrations
4.2.4. By Region
126.96.36.199. North America
188.8.131.52. South America
184.108.40.206. Middle East & Africa
4.2.5. By Company
220.127.116.11. Revenue Shares
18.104.22.168. Strategic Factorial Indexing
22.214.171.124. Competitor Placement in MarkNtel Quadrant
5. North America Hematology Diagnostics Market Analysis, 2015-2025F
5.1. Market Size & Analysis
5.1.1. Market Revenue
5.2. Market Share & Analysis
5.2.1. By Product Type
5.2.2. By End User
5.2.3. By Consumables
5.2.4. By Country
126.96.36.199. United States
5.3. United States Hematology Diagnostics Market Analysis, 2015-2025F